ArticlePeerJ2022

Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation.

Mindi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.